Workflow
DIAN DIAGNOSTICS(300244)
icon
Search documents
AIGC概念股继续上涨,浙文互联涨停
Ge Long Hui· 2026-01-23 03:09
1月23日,A股市场部分AIGC概念股继续上涨,其中,浙文互联涨停,世纪天鸿涨超7%,光云科技、超 图软件、迪安诊断、千方科技涨超5%,九州通、当虹科技、垒知集团、福石控股、科大国创、岩山科 技、中控技术涨超4%。 | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 600986 | 浙文互联 | 1 | 10.05 | 179亿 | 54.09 | | 300654 | 世纪天鸿 | | 7.63 | 42.36亿 | 16.75 | | 688365 | 光云科技 | | 5.91 | 113亿 | 57.32 | | 300036 | 超图软件 | 演 | 5.34 | 99.10亿 | 10.74 | | 300244 | 迪安诊断 | 豪 | 5.27 | 174亿 | 75.21 | | 002373 | 千方科技 | 兼 | 5.24 | 209亿 | 12.57 | | 600998 | 九州通 | 1 | 4.90 | 281亿 | 8.79 | | 688039 | 当虹科技 | | ...
1月21日生物经济(970038)指数涨0.3%,成份股迪安诊断(300244)领涨
Sou Hu Cai Jing· 2026-01-21 10:40
证券之星消息,1月21日,生物经济(970038)指数报收于2249.37点,涨0.3%,成交272.77亿元,换手 率2.27%。当日该指数成份股中,上涨的有28家,迪安诊断以5.59%的涨幅领涨,下跌的有22家,康弘药 业以1.78%的跌幅领跌。 生物经济(970038)指数十大成份股详情如下: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000021 | 深科技 | 1.87亿 ﮯ | 3.06% | -9441.13万 | -1.55% | -9272.83万 | -1.52% | | 300142 | 沃森生物 | 6444.78万 | 8.62% | -3115.26万 | -4.16% | -3329.52万 | -4.45% | | 000930 | 中粮科技 | 5427.62万 | 9.84% | 491.65万 | 4 0.89% | -5919.27万 | -10.73% | | 002 ...
精准医疗板块1月21日涨0.1%,迪安诊断领涨,主力资金净流入7998.53万元
Sou Hu Cai Jing· 2026-01-21 09:01
证券之星消息,1月21日精准医疗板块较上一交易日上涨0.1%,迪安诊断领涨。当日上证指数报收于 4116.94,上涨0.08%。深证成指报收于14255.12,上涨0.7%。精准医疗板块个股涨跌见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 从资金流向上来看,当日精准医疗板块主力资金净流入7998.53万元,游资资金净流入5509.4万元,散户 资金净流出1.35亿元。精准医疗板块个股资金流向见下表: ...
医疗服务板块1月21日涨0.18%,南模生物领涨,主力资金净流入5050.97万元
证券之星消息,1月21日医疗服务板块较上一交易日上涨0.18%,南模生物领涨。当日上证指数报收于 4116.94,上涨0.08%。深证成指报收于14255.12,上涨0.7%。医疗服务板块个股涨跌见下表: 从资金流向上来看,当日医疗服务板块主力资金净流入5050.97万元,游资资金净流入3.24亿元,散户资 金净流出3.75亿元。医疗服务板块个股资金流向见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 49.79 | 7.01% | 2.00万 | i 9802.06万 | | 300683 | 海特生物 | 29.67 | 5.74% | 10.78万 | 3.22 Z | | 300244 | 迪安诊断 | 26.46 | 5.59% | 79.63万 | 21.30亿 | | 600568 | ST中珠 | 2.64 | 5.18% | 37.65万 | 9806.43万 | | 600763 | 通策医疗 | 46.51 | 4.99% | 19. ...
A股AI应用概念股回升,久其软件、浙文互联涨停
Ge Long Hui A P P· 2026-01-21 03:32
Group 1 - The A-share market has seen a rebound in AI application concept stocks, with Shanghai Steel Union rising over 11% [1] - Other notable gainers include Jiuqi Software and Zhejiang Wenhu Internet, both hitting the 10% limit up, while Jinxi Modern and Zhongkong Technology increased by over 9% [1] - The overall trend indicates a positive momentum in the AI sector, as evidenced by the MACD golden cross signal formation [2] Group 2 - Shanghai Steel Union's market capitalization is approximately 9.791 billion, with a year-to-date increase of 22.29% [2] - Jiuqi Software has a market cap of around 8.217 billion and a year-to-date increase of 19.27% [2] - Zhejiang Wenhu Internet's market cap stands at about 16.3 billion, with a significant year-to-date increase of 40.28% [2]
DRG/DIP概念下跌4.34%,主力资金净流出22股
Core Insights - The DRG/DIP concept has experienced a decline of 4.34%, ranking among the top losers in the concept sector as of the market close on January 16 [1] - Major stocks within the DRG/DIP sector, such as Weining Health, Dian Diagnostics, and Jiahe Meikang, have seen significant drops [1] Market Performance - The DRG/DIP concept faced a net outflow of 1.926 billion yuan from main funds today, with 22 stocks experiencing net outflows, and 8 stocks seeing outflows exceeding 50 million yuan [2] - Weining Health led the outflows with a net withdrawal of 669.34 million yuan, followed by Dian Diagnostics with 332.21 million yuan, and Donghua Software with 171.22 million yuan [2] Stock-Specific Data - Weining Health reported a decline of 13.20% with a turnover rate of 17.31% and a main fund flow of -669.34 million yuan [3] - Dian Diagnostics fell by 12.86% with a turnover rate of 21.16% and a main fund flow of -332.21 million yuan [3] - Other notable declines include Donghua Software at -3.33% and Rongke Technology at -2.74% [3][4]
医疗服务板块1月16日跌2.51%,迪安诊断领跌,主力资金净流出25.83亿元
证券之星消息,1月16日医疗服务板块较上一交易日下跌2.51%,迪安诊断领跌。当日上证指数报收于 4101.91,下跌0.26%。深证成指报收于14281.08,下跌0.18%。医疗服务板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 301509 | 金凯生松 | 38.43 | 2.15% | | 5.17万 | 1.96亿 | | 301096 | 百诚医药 | 59.40 | 1.50% | | 3.12万 | 1.84亿 | | 600721 | 自花医药 | 9.84 | 0.92% | | 28.61万 | 2.79亿 | | 002821 | 凯莱英 | 107.33 | 0.78% | | 5.97万 | 6.39亿 | | 603259 | 药明康德 | 104.30 | 0.71% | | 44.78万 | 46.80亿 | | 688621 | 阳光诺和 | 75.88 | 0.44% | | 2.41万 | 1.82亿 | | 688 ...
马斯克预言机器人3年干翻外科医生?AI医疗股5天悄悄翻倍
Sou Hu Cai Jing· 2026-01-14 08:42
马斯克又开"预言家"模式了!这次直接把矛头对准外科医生,放话3年让擎天柱机器人干翻顶尖外科医 生,以后学医没用。不过,马斯克画饼画得飞起,医学界大佬们可坐不住了。 "定海神针"张文宏医生直接泼了盆冷水: 这边"人机大战"的口水仗还没分出胜负,那边AI医疗的热度已经被焊死在热搜上。网友虽然吵得不可开 交,但股民可没工夫等三年五载验证预言,反手就给AI医疗板块安排了一场"涨停大合唱"。泓博医药、 迪安诊断这些相关公司,五天涨幅直接翻倍,从上游算力、大模型,到中游医疗信息化,再到下游制 药、医院,整个产业链集体狂欢。 股民的心态简直真实到扎心:管它未来是机器抢医生饭碗,还是当医生的"超级外挂",这波技术变革的 钱,先赚了再说! 大佬们也没闲着,AI芯片一哥英伟达砸10亿美元重仓AI制药;OpenAI悄悄收购医疗数据公司,摆明要 打通医疗数据"任督二脉"。他们争夺的,是医疗AI时代的"水电煤"和"数据燃料。明眼人都懂,不管未 来是AI主导还是医生主场,科技巨头的卡位赛已全力冲刺。 那么,我们到底该怎么看这场热闹?说到底,技术变革总会伴随着争议,但资本市场永远快人一步。至 于未来看病会不会真的靠机器人,咱们慢慢看。 ...
AI应用板块暴涨6.6%!值得买等4股20CM涨停,2026年商业化元年来临,GEO市场潜力巨大
Jin Rong Jie· 2026-01-14 03:07
Core Viewpoint - The AI application sector is experiencing significant growth, with a 6.6% increase in early trading, driven by advancements in AI technology and its commercial applications across various industries [1][2]. Group 1: Market Performance - The AI application sector saw a total trading volume exceeding 7.917 billion yuan, with 74 stocks participating in the trading [1]. - Notable stocks such as Zhuoyi Information, Zhide Mai, and Guangyun Technology reached the daily limit increase of 20%, while several others saw increases exceeding 8% [1]. Group 2: Industry Trends - The market is currently focused on the accelerated commercialization of AI applications, particularly in marketing, e-commerce, healthcare, and media, as the cost of inference decreases and model capabilities improve [2][3]. - Institutions predict that 2026 will be a pivotal year for AI applications, marking a transition from technology validation to commercial promotion [2][3]. Group 3: Growth Projections - According to a report by the China Business Advertising Association, the global GEO market is expected to reach $11.2 billion by 2025, with the Chinese market projected at 2.9 billion yuan [3]. - By 2030, the global GEO market is anticipated to grow to $100.7 billion, with a 5-year CAGR of 55%, while the Chinese market is expected to reach 24 billion yuan, with a 5-year CAGR of 53% [3]. Group 4: Sector-Specific Insights - AI marketing is evolving with the rise of generative search (GEO), transforming traditional search engine optimization into a necessity for marketing [5]. - AI applications in e-commerce, healthcare, office automation, and media are becoming increasingly prevalent, providing significant growth opportunities for companies in these sectors [6].
OpenAI6000万美元收购医疗科技公司!医疗器械ETF(562600)冲击5连阳,迪安诊断大涨12%
Sou Hu Cai Jing· 2026-01-14 02:58
Group 1 - The A-share market saw all three major indices rise, with the medical device ETF (562600) increasing by 2.30% in early trading [1] - AI applications in the medical sector continued to perform strongly, with notable stock increases: Dean Diagnostics surged by 12.48%, Yuyue Medical rose by 9.10%, Tianzhihang increased by 6.99%, and Kingmed Diagnostics went up by 5.02% [1] - The medical device ETF (562600) has attracted significant capital, with a net inflow of 91 million yuan over the past five days and a trading volume of 26.96 million yuan at the time of reporting [1] Group 2 - OpenAI has invested $60 million to acquire the medical technology startup Torch, enhancing its AI healthcare strategy. The acquisition focuses on developing a "unified medical memory" system to integrate disparate patient health data [1] - The medical device industry is experiencing robust growth, with the medical device ETF (562600) tracking the CSI All Index for medical devices, which has a 23.8% allocation to brain-computer interface stocks, the highest among listed ETFs [2] - The ETF's high concentration in the medical device sector, at 89.2%, allows for effective capture of growth opportunities in niche markets [2]